RVMD — Revolution Medicines Share News
0.000.00%
Last trade - 00:00- $40.57bn
- $37.66bn
U.S. STOCKS ON THE MOVE-Nike, PNC Financial, Papa John's
Tango Therapeutics rises after leadership changes ahead of cancer drug data
U.S. STOCKS ON THE MOVE-Gitlab, Snap, Robinhood
Revolution Medicines falls premarket after doubling capital raise to $2 bln
U.S. STOCKS ON THE MOVE-BlackRock, MDA Space, Revolution Medicines
Revolution Medicines reaches record on strong pancreatic cancer trial results
Street View: Analysts upbeat on Revolution pancreatic cancer drug
Brief: Revolution Medicines, Inc. Announces Proposed Offerings Of Common Stock And Convertible Senior Notes
Revolution Medicines dips after announcing $1 bln raise following pancreatic cancer drug data
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Revolution Medicines jumps after pancreatic cancer drug extends survival
Revolution Medicines jumps after pancreatic cancer drug extends survival
Revolution Medicines' experimental cancer pill helps improve survival in late-stage study (updated)
Brief: Revolution Medicines Says Daraxonrasib Shows Improvement In Survival In Late-Stage Pancreatic Cancer Study
Revolution Medicines' experimental cancer pill helps improve survival in late-stage study
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
Brief: Revolution Medicines Inc Files For Common Stock Offering Of Up To $1.0 Billion
Revolution Medicines Q4 net loss widens